Skip to main content

Table 4 Toxicity profile for all patients

From: Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Side effects

TKI-naïve (%) (N = 207)

TKI-resistant (N = 137)

All grades, N. (%)

Grade III/IV, N. (%)

All grades, N. (%)

Grade III/IV, N. (%)

Fatigue

117 (56.5)

19 (9.1)

81 (59.1)

14 (10.2)

Anorexia

84 (40.5)

18 (8.7)

56 (40.9)

10 (7.3)

Diarrhea

23 (11.1)

4 (0.2)

12 (8.8)

1 (0.7)

Nausea

142 (68.6)

38 (18.4)

95 (69.3)

23 (16.8)

Vomiting

134 (64.7)

15 (7.2)

83 (60.6)

15 (10.9)

Headache

105 (50.7)

14 (6.8)

51 (37.2)

12 (8.8)

Anemia

113 (54.6)

5 (2.4)

75 (54.1)

3 (2.2)

Neutropenia

95 (45.9)

17 (8.2)

69 (50.4)

11 (8.0)

Thrombocytopenia

88 (42.5)

6 (2.9)

62 (45.3)

2 (1.5)

  1. Abbreviations: TKI tyrosine kinase inhibitors